{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:55:20Z","timestamp":1766134520814,"version":"3.48.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006309","name":"Riisfort Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pnpbp.2025.111572","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:14:35Z","timestamp":1764749675000},"page":"111572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Agomelatine normalizes region-specific, diurnal mGluR5 dysregulation in a chronic mild stress rat model of depression"],"prefix":"10.1016","volume":"143","author":[{"given":"Celine","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majken B.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"H\u00f8jgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie L.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ove","family":"Wiborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi K.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betina","family":"Elfving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111572_bb0005","first-page":"449","article-title":"Metabotropic glutamate receptor 5 and glutamate involvement in major depressive disorder: a multimodal imaging study","volume":"2","author":"Abdallah","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S2215-0366(21)00390-4","article-title":"Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries","volume":"9","author":"Arango","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0015","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00787-024-02587-4","article-title":"Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study","volume":"34","author":"Arango","year":"2025","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0020","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1046\/j.1460-9568.2000.00131.x","article-title":"Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy","volume":"12","author":"Aronica","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0025","series-title":"International Review of Neurobiology","first-page":"265","article-title":"Chapter six - the metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders","author":"Asch","year":"2023"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41386-024-01913-3","article-title":"Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression","volume":"50","author":"Asch","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.104079","article-title":"A single subanaesthetic dose of the rapid-acting antidepressant S-ketamine raises presynaptic SV2A density in limbic regions of the Wistar Kyoto rat model of depression","volume":"3","author":"B\u00e6rentzen","year":"2024","journal-title":"Neurosci. Appl."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0040","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","article-title":"Differential expression of synaptic vesicle protein 2 (SV2) isoforms","volume":"14","author":"Bajjalieh","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pcn.12604","article-title":"Neural basis of major depressive disorder: beyond monoamine hypothesis","volume":"72","author":"Boku","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0050","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/acsptsci.4c00621","article-title":"Synaptic vesicle 2A (SV2A) positron emission tomography (PET) imaging as a marker of therapeutic response in a mouse model of depression","volume":"8","author":"Corvo","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.yhbeh.2008.10.015","article-title":"From daily behavior to hormonal and neurotransmitters rhythms: comparison between diurnal and nocturnal rat species","volume":"55","author":"Cuesta","year":"2009","journal-title":"Horm. Behav."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0070","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","article-title":"Agomelatine, the first melatonergic antidepressant: discovery, characterization and development","volume":"9","author":"de Bodinat","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0075","doi-asserted-by":"crossref","first-page":"8982","DOI":"10.1038\/s41598-022-13029-z","article-title":"mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington\u2019s disease phenotype","volume":"12","author":"de Souza","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/appi.ajp.2011.09111607","article-title":"Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study","volume":"168","author":"Deschwanden","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/15622975.2020.1851052","article-title":"A clinical approach to treatment resistance in depressed patients: what to do when the usual treatments don\u2019t work well enough?","volume":"22","author":"Dodd","year":"2021","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/npp.2017.294","article-title":"Neuronal mechanisms for sleep\/wake regulation and modulatory drive","volume":"43","author":"Eban-Rothschild","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0105","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/jsr.12432","article-title":"Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain","volume":"25","author":"Elmenhorst","year":"2016","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/mp.2017.58","article-title":"Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression","volume":"23","author":"Esterlis","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopsych.2017.08.025","article-title":"Metabotropic glutamatergic receptor 5 and stress disorders: knowledge gained from receptor imaging studies","volume":"84","author":"Esterlis","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002210000633","article-title":"Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2\/3 and 5","volume":"137","author":"Ferraguti","year":"2001","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0125","doi-asserted-by":"crossref","first-page":"348ra396","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hup.964","article-title":"Circadian rhythm disturbances in depression","volume":"23","author":"Germain","year":"2008","journal-title":"Hum. Psychopharmacol."},{"year":"2019","series-title":"Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets","author":"Griem-Krey","key":"10.1016\/j.pnpbp.2025.111572_bb0135"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0140","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-017-4781-8","article-title":"Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment","volume":"235","author":"H\u00f8jgaard","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0145","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41386-022-01368-4","article-title":"Imaging synaptic density in depression","volume":"48","author":"Holmes","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0155","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.biopsych.2022.10.018","article-title":"Differences in quantification of the metabotropic glutamate receptor 5 across bipolar disorder and major depressive disorder","volume":"93","author":"Holmes","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0160","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.12998\/wjcc.v9.i31.9350","article-title":"Major depressive disorder: validated treatments and future challenges","volume":"9","author":"Karrouri","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biopsych.2022.01.006","article-title":"Metabotropic glutamate receptor 5 in amygdala target neurons regulates susceptibility to chronic social stress","volume":"92","author":"Kim","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0170","article-title":"Depressive-like behaviors induced by mGluR5 reduction in 6xTg in mouse model of Alzheimer\u2019s disease","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0175","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.brainresbull.2012.01.010","article-title":"Reduced metabotropic glutamate receptor 5 in the Flinders sensitive line of rats, an animal model of depression: an autoradiographic study","volume":"87","author":"Kova\u010devi\u0107","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0180","doi-asserted-by":"crossref","first-page":"14072","DOI":"10.1074\/jbc.M708551200","article-title":"Activated nuclear metabotropic glutamate receptor mGlu5 couples to nuclear Gq\/11 proteins to generate inositol 1,4,5-trisphosphate-mediated nuclear Ca2+ release*","volume":"283","author":"Kumar","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0185","article-title":"Neurobiology of depression: chronic stress alters the glutamatergic system in the brain-focusing on AMPA receptor","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7060117","article-title":"The impact and mechanism of methylated metabotropic glutamate receptors 1 and 5 in the Hippocampus on depression-like behavior in prenatal stress offspring rats","volume":"7","author":"Lin","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuron.2010.01.016","article-title":"Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease","volume":"65","author":"L\u00fcscher","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0200","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/jnc.14307","article-title":"Alterations in mGlu5 receptor expression and function in the striatum in a rat depression model","volume":"145","author":"Mao","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0210","doi-asserted-by":"crossref","first-page":"1173200","DOI":"10.3389\/fncel.2023.1173200","article-title":"Reactive astrogliosis in the era of single-cell transcriptomics","volume":"17","author":"Matusova","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroscience.2019.09.004","article-title":"Analysis of differential expression of synaptic vesicle protein 2A in the adult rat brain","volume":"419","author":"Mendoza-Torreblanca","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0220","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-011-2280-x","article-title":"Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats","volume":"217","author":"Morley-Fletcher","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0230","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2967\/jnumed.115.168179","article-title":"Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain","volume":"57","author":"Nabulsi","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0235","series-title":"The Neuroscience of Depression","first-page":"301","article-title":"Chapter 30 - Agomelatine: Profile and applications to depression","author":"Norman","year":"2021"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.npp.1300091","article-title":"Effect of Agomelatine in the chronic mild stress model of depression in the rat","volume":"28","author":"Papp","year":"2003","journal-title":"Neuropsychopharmacology"},{"year":"1998","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.pnpbp.2025.111572_bb0245"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0250","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/15622975.2013.765593","article-title":"Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review","volume":"14","author":"Pompili","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0255","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hup.1112","article-title":"Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients","volume":"25","author":"Quera-Salva","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0260","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/15622975.2011.595823","article-title":"Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors","volume":"12","author":"Racagni","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0265","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/s41380-024-02541-5","article-title":"Loss of mGlu5 receptors in somatostatin-expressing neurons alters negative emotional states","volume":"29","author":"Ramos-Prats","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0270","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/hbm.24976","article-title":"mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia","volume":"41","author":"R\u00e9gio Brambilla","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.864514","article-title":"Synaptic vesicle glycoprotein 2A: features and functions","volume":"16","author":"Rossi","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.796129","article-title":"Imaging synaptic density: the next holy grail of neuroscience?","volume":"16","author":"Serrano","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0285","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1358\/dnp.2005.18.6.927927","article-title":"The role of metabotropic glutamate receptor 5 in learning and memory processes","volume":"18","author":"Simonyi","year":"2005","journal-title":"Drug News Perspect."},{"issue":"Suppl. 3","key":"10.1016\/j.pnpbp.2025.111572_bb0290","doi-asserted-by":"crossref","first-page":"S482","DOI":"10.1016\/j.euroneuro.2012.06.016","article-title":"Synergistic mechanisms involved in the antidepressant effects of agomelatine","volume":"22","author":"Tardito","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fphar.2012.00189","article-title":"Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases","volume":"3","author":"Wang","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111572_bb0300","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroscience.2015.06.008","article-title":"Prenatal chronic mild stress induces depression-like behavior and sex-specific changes in regional glutamate receptor expression patterns in adult rats","volume":"301","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0305","first-page":"659","article-title":"Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in the rat hippocampus in an animal model of depression","volume":"53","author":"Wiero\u0144ska","year":"2001","journal-title":"Pol. J. Pharmacol."},{"year":"2017","series-title":"\u201cDepression: Let\u2019s Talk\u201d says WHO, as Depression Tops List of Causes of Ill Health","author":"World Health Organization","key":"10.1016\/j.pnpbp.2025.111572_bb0310"},{"year":"2025","series-title":"Depressive Disorder (Depression)","author":"World Health Organization","key":"10.1016\/j.pnpbp.2025.111572_bb0315"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0320","series-title":"Core Psychiatry","first-page":"585","article-title":"39 - psychopharmacology","author":"Wright","year":"2012"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0325","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12888-025-06941-x","article-title":"Comparative efficacy of antidepressant medication for adolescent depression: a network meta-analysis and systematic review","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111572_bb0330","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.biopsych.2024.11.016","article-title":"Variations in brain glutamate and glutamine levels throughout the sleep-wake cycle","volume":"98","author":"Yoon","year":"2025","journal-title":"Biol. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625003264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625003264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:52:53Z","timestamp":1766134373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625003264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"alternative-id":["S0278584625003264"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111572","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agomelatine normalizes region-specific, diurnal mGluR5 dysregulation in a chronic mild stress rat model of depression","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111572"}}